Form 8-K - Current report:
SEC Accession No. 0001558370-23-004930
Filing Date
2023-03-29
Accepted
2023-03-29 16:23:26
Documents
14
Period of Report
2023-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230329x8k.htm   iXBRL 8-K 36539
2 EX-99.1 tmb-20230329xex99d1.htm EX-99.1 146747
3 GRAPHIC tmb-20230329xex99d1001.jpg GRAPHIC 8335
  Complete submission text file 0001558370-23-004930.txt   323962

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20230329.xsd EX-101.SCH 3055
5 EX-101.LAB tmb-20230329_lab.xml EX-101.LAB 15357
6 EX-101.PRE tmb-20230329_pre.xml EX-101.PRE 10021
8 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230329x8k_htm.xml XML 4670
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 23775541
SIC: 2834 Pharmaceutical Preparations